United States · FDA National Drug Code directory

Dacarbazine

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 71288-174_94e81c40-cf9b-45fa-a396-044196081d48
Product NDC: 71288-174
Form: INJECTION, POWDER, FOR SOLUTION
Composition / generic term: Dacarbazine
Labeler: Meitheal Pharmaceuticals Inc.
Marketing category: ANDA
Marketing start / end (source format): 20240422
Source listing expiry: 20261231

Source-listed ingredients

DACARBAZINE — 200 mg/20mL

These values do not establish equivalence or a dose recommendation.

Packages

10 VIAL, SINGLE-USE in 1 CARTON (71288-174-21) / 20 mL in 1 VIAL, SINGLE-USE (71288-174-20) · 71288-174-21

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →